• Acquisition adds a new growth vertical to Abbott’s already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segments•...read more
Category - Data analysis/bioinformatics
BEVIMI Launches: A New Bid to Bring Pharma-Grade Rigor to Brain Health
This past week, BEVIMI was officially announced. This new company aims to bring pharmaceutical-style rigor to the consumer brain-health market. Headquartered in Greenwich, Connecticut and led by co-founders Paul...read more
Why Are We Still Talking About Data Infrastructure for Life Sciences in 2025?
“In my twenty-five years in the Life Sciences industry, I’ve observed countless organizations adopt, revise, dismantle, and rebuild their data infrastructure.” While the rapid advancements of data technology certainly...read more
It’s Not the Quantity but the Quality of Data That Enables AI/ML-Based Bioprocess Applications
Over the past 30 years, product titers have increased by almost 20% year over year (Langer and Rader, 2015). Since the 1990s, this has translated into dramatic increases in production, from an average of <1g/L to...read more
